Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Moxiwel
Moxiwel is an advanced antibiotic eye drop containing Moxifloxacin 0.5%, designed for the treatment of bacterial eye infections. It offers rapid action against a wide range of pathogens, ensuring effective infection control and reducing symptoms such as redness, itching, and discomfort.
Uses of Moxiwel
Moxiwel is indicated for the treatment of:
Bacterial Conjunctivitis (Pink Eye)
Bacterial Blepharitis (Eyelid Inflammation)
Keratitis (Corneal Infection)
Other Eye Infections Caused by Susceptible Bacteria
Benefits of Moxiwel
Effective Against Common Ocular Pathogens
Rapid Relief from Redness, Irritation, and Discomfort
Broad-Spectrum Activity Against Gram-Positive and Gram-Negative Bacteria
Minimal Systemic Absorption & Localized Action
Well-Tolerated for Short-Term Use
Mechanism of Action of Moxiwel
Moxiwel works by inhibiting DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair. This results in bacterial cell death and effective eradication of the infection. Its potent bactericidal action ensures rapid resolution of symptoms.